Safety and efficacy of long-term combination therapy with bezafibrate and ezetimibe in patients with dyslipidemia in the prospective, observational J-COMPATIBLE study
Conclusions:
Bezafibrate in combination with ezetimibe is safe and effective, and is potentially useful for comprehensive management of dyslipidemia.
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Tamio TeramotoKazunori AbeTakehiko Taneyama Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Drugs & Pharmacology | Endocrinology | Fenofibrate | Gallstones | Heart | Study | Tricor | Vytorin | Zetia